Cannabis-focused finance company FundCanna has secured a new institutional funding arrangement that could significantly expand its lending activity at a time when cannabis operators continue to face tight liquidity conditions and limited access to traditional banking services.
The San Diego-based lender announced that it now has access to approximately $75 million in capital, including $35 million immediately available for deployment, following a partnership with an institutional investment firm that manages roughly $40 billion in assets. The agreement includes a $60 million senior credit facility that FundCanna intends to use to scale its lending operations and payment solutions for cannabis businesses.
Institutional Capital Continues Moving Into Cannabis Finance
Institutional capital has historically been cautious about entering cannabis lending, particularly unsecured lending tied to plant-touching operators. Federal prohibition, inconsistent state regulations, limited bankruptcy protections, and ongoing banking restrictions have kept many traditional financial institutions on the sidelines.
FundCanna’s latest financing arrangement suggests that at least some institutional investors are becoming more comfortable with the sector’s risk profile, especially as cannabis markets mature and financial infrastructure improves.
The company said part of the new capital will support the expansion of its ReadyPaid platform, a buy-now-pay-later style solution designed for cannabis wholesalers and retailers. The service allows vendors to receive payment upfront while giving buyers longer repayment terms, addressing one of the industry’s most persistent operational problems: delayed invoice payments and strained cash flow.
Cannabis Operators Still Face Major Liquidity Challenges
Accounts receivable issues have become increasingly problematic across regulated cannabis markets in the United States. Industry estimates cited by the company place delinquent receivables near $4 billion, highlighting the scale of payment bottlenecks affecting cultivators, manufacturers, distributors, and retailers.
Credit availability remains one of the biggest structural constraints on the regulated marijuana industry. Many operators continue to struggle with high borrowing costs, limited working capital, and restricted access to mainstream financial services despite generating significant revenue.
FundCanna appears to be positioning itself as an infrastructure lender capable of serving both large multi-state operators and smaller businesses throughout the supply chain. The company said it has already deployed more than $250 million through over 5,000 transactions and is approaching $100 million in annualized lending volume.
Schedule III Reform May Be Improving Investor Sentiment
The financing package also signals growing investor interest in ancillary cannabis businesses rather than direct plant-touching operators. Ancillary firms often face fewer regulatory hurdles while still benefiting from broader industry expansion. In recent years, institutional investors have increasingly preferred companies that provide software, logistics, payments, or financing services to cannabis operators rather than directly participating in cultivation or retail.
Timing may also be playing a role in renewed institutional interest.
The cannabis financing landscape has been evolving since the U.S. federal government finalized the reclassification of medical cannabis to Schedule III earlier this year. While the regulatory change does not fully legalize cannabis federally, it has improved sentiment among investors and lenders who previously viewed the sector as too legally uncertain.
Market participants are also watching for additional reforms that could further reduce barriers between the cannabis industry and traditional financial markets. Even incremental federal changes could improve access to banking services, lower capital costs, and increase participation from institutional lenders.
ReadyPaid Platform Targets Wholesale Payment Bottlenecks
For companies like FundCanna, those developments could create substantial growth opportunities.
The company indicated that the new facility could support more than $500 million in cumulative funding over the coming years, potentially allowing it to scale beyond its current transaction volume and deepen relationships with larger cannabis operators focused on wholesale distribution growth.
Wholesale distribution has become increasingly important in the regulated cannabis economy as competition intensifies across mature state markets. Brands are under pressure to expand shelf presence and retail partnerships while preserving cash reserves. Financing solutions that shorten payment cycles or extend purchasing flexibility can therefore become critical operational tools.
FundCanna’s ReadyPaid platform appears designed specifically for that environment. Instead of vendors acting as informal lenders while waiting for retailers to pay invoices, the platform provides sellers with immediate liquidity while shifting repayment obligations into structured financing arrangements.
Cannabis Lending Still Carries Significant Risks
FundCanna’s leadership emphasized that experience underwriting cannabis transactions played a major role in attracting institutional backing. The cannabis sector remains highly fragmented, with varying state laws, inconsistent reporting standards, and limited access to reliable financial data. Specialized lenders with long operating histories may therefore hold a competitive advantage over newer entrants attempting to navigate the sector.
The involvement of an investment bank in arranging the deal also highlights how cannabis finance transactions are becoming more sophisticated. As institutional participation increases, companies with proven lending histories, disciplined underwriting practices, and scalable operational infrastructure may become attractive acquisition or partnership targets.
Still, risks remain.
Cannabis operators continue to face margin compression in several major state markets, including California, Colorado, and Michigan. Oversupply, taxation, competition from the illicit market, and pricing pressure have weakened balance sheets across the industry. Any lender expanding aggressively into cannabis credit markets must still manage elevated default risks and regulatory uncertainty.
Institutional appetite also remains selective. While sentiment has improved, many major financial institutions continue to avoid direct cannabis exposure entirely. Broader participation will likely depend on additional federal reforms, clearer banking protections, and stronger profitability trends among cannabis businesses.

